Fairvalue-Calculator Fairvalue-Calculator
EN DE

Inogen, Inc (INGN) Fair Value & Analysis

Healthcare · US · Market cap $174M

Price$6.76
Fair Value$3.39
Upside-49.9%
Quality95/100
Evidence: Low Range $2.24 – $4.24

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Inogen, Inc (INGN) currently trades at $6.76, while our model-based Fair Value estimate is $3.39 — implying the stock looks roughly 49.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is Inogen, Inc (INGN) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $3.39 versus a price of $6.76 — about −50% (overvalued). Model-based estimate, not financial advice.
What is the fair value of INGN?
Our 21-model fair value for Inogen, Inc is $3.39 (as of Jun 25, 2026), built from audited fundamentals. The current price is $6.76.
What is the quality score of INGN?
Inogen, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.